APA (7th ed.) Citation

Balbach, M. L., & Johnson, D. B. (2026). Clinical Characteristics and Management of Immune Checkpoint Inhibitor-Associated Sicca Syndrome. Cancers, 18(11), 1836. https://doi.org/10.3390/cancers18111836

Chicago Style (17th ed.) Citation

Balbach, Meridith L., and Douglas B. Johnson. "Clinical Characteristics and Management of Immune Checkpoint Inhibitor-Associated Sicca Syndrome." Cancers 18, no. 11 (2026): 1836. https://doi.org/10.3390/cancers18111836.

MLA (9th ed.) Citation

Balbach, Meridith L., and Douglas B. Johnson. "Clinical Characteristics and Management of Immune Checkpoint Inhibitor-Associated Sicca Syndrome." Cancers, vol. 18, no. 11, 2026, p. 1836, https://doi.org/10.3390/cancers18111836.